-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Chemours, Lowers Price Target to $24

Benzinga·08/06/2026 16:10:53
Listen to the news
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $30 to $24.